tRNA modifications tune m6A-dependent mRNA decay.
Options
BORIS DOI
Publisher DOI
PubMed ID
40311619
Description
Chemically modified nucleotides in mRNA are critical regulators of gene expression, primarily through interactions with reader proteins that bind to these modifications. Here, we present a mechanism by which the epitranscriptomic mark N6-methyladenosine (m6A) is read by tRNAs during translation. Codons that are modified with m6A are decoded inefficiently by the ribosome, rendering them "non-optimal" and inducing ribosome collisions on cellular transcripts. This couples mRNA translation to decay. 5-Methoxycarbonylmethyl-2-thiouridine (mcm5s2U) in the tRNA anticodon loop counteracts this effect. This unanticipated link between the mRNA and tRNA epitranscriptomes enables the coordinated decay of mRNA regulons, including those encoding oncogenic signaling pathways. In cancer, dysregulation of the m6A and mcm5s2U biogenesis pathways-marked by a shift toward more mcm5s2U-is associated with more aggressive tumors and poor prognosis. Overall, this pan-epitranscriptomic interaction represents a novel mechanism of post-transcriptional gene regulation with implications for human health.
Date of Publication
2025-07-10
Publication Type
article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
N(6)-methyladenosine
•
cancer
•
epitranscriptome
•
m(6)A
•
mRNA decay
•
mRNA translation
•
mcm(5)s(2)U
•
oncogenic signaling
•
ribosome collisions
•
tRNA modification
Language(s)
en
Contributor(s)
Linder, Bastian | |
Murakami, Shino | |
Ott, Roman E | |
Fenzl, Kai | |
Vorgerd, Hannah | |
Erhard, Florian | |
Jaffrey, Samie R | |
Steinmetz, Lars M |
Additional Credits
Graduate School for Cellular and Biomedical Sciences (GCB)
DCBP Gruppe Prof. Leidel
Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP)
Series
Cell
Publisher
Elsevier
ISSN
1097-4172
0092-8674
Access(Rights)
open.access